When chemical reactions in the human body are disrupted, it can result in many different types of metabolic disorders; each with varying symptoms that can include high blood pressure, high sugar level and excessive body fat.

Supported by researchers and investigators, UNSW aims to address these disorders and develop new treatments and strategies. Our researchers are currently looking to combat metabolic diseases such as cardiovascular disease, fatty liver disease, obesity, type 2 diabetes and cancer. We have strong expertise in the fields of lipid and glucose metabolism and use state-of-the art techniques to better understand how altering cellular metabolism impacts metabolic diseases.

Students are trained in molecular cell biology, drug discovery/development, animal physiology, pharmacology, and pre-clinical disease models. Our students develop skills in data interpretation, report writing, oral presentation, leadership/teamwork, and analytical techniques such as mass spectrometry.

UNSW research in metabolism and metabolic disorders has undergone considerable growth in scope and output, producing high impact publications and secured national competitive grants. Notably, UNSW School of Biotechnology and Biomolecular Sciences Professor Rob Yang carried out extensive research into metabolic disorders with a breakthrough discovery in the transportation of cholesterol in cells. This new knowledge can be applied to developing drugs that will boost good cholesterol and alleviate the risk of heart disease and stroke in the years to come. 

Professor H Robert Yang and Dr Ivan Lukmantara
Professor H Robert Yang and Dr Ivan Lukmantara

 

Related people